arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

BAXTER INTERNATIONAL INC

BAX
$25.63 ▼ -0.86 (-3.25%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
76 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

BAXTER INTERNATIONAL INC faces fundamental challenges with weakness in Profit Margin (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.

Market Cap $13.3B
Dividend Yield 0.04%
Revenue Growth 5.0% ↘
Op. Margin 7.6% ↗
ROIC 2.5% ↘
FCF / Share $1.08 ↗
Trailing P/E 45.0x
Price / Book 2.0x
FCF Yield 4.2%
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Nov 5, 2026.

76-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.98B
↑ +5.0% —
Net Income Profit after all expenses
$294.00M
↑ +133.3% —
Operating Margin Operating profit as % of sales
7.6%
↑ +3.1% 23th
FCF / Share Free cash flow per share
$1.08
↑ +95.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
31
Returns
30
Financial Health ↓
31
Cash Quality
11

Dividend History

Dividend / share · sourced from SEC filings
$0.52 Latest / share
-50.0% YoY
-11.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 20 years · 76 quarters